title: Is the use of NMBA dissuaded in individuals who display positive sIgE to QAS?
authors.affiliation: Faculty of Medicine and Health Science, Department of Immunology, Allergology and Rheumatology, University Antwerp and Antwerp University Hospital, Antwerpen, Belgium.
authors.forename: J
authors.initials: J
authors.lastname: Leysen
authors.forename: V
authors.initials: V
authors.lastname: Sabato
authors.forename: C
authors.initials: C
authors.lastname: Bridts
authors.forename: D G
authors.initials: DG
authors.lastname: Ebo
mesh_terms: D000777:Anesthetics / Q000276:immunology*; D004342:Drug Hypersensitivity / Q000453:epidemiology*; D005260:Female; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology*; D008297:Male; D009466:Neuromuscular Blocking Agents / Q000276:immunology*; D016273:Occupational Exposure / Q000009:adverse effects*
chemical_list: D000777:Anesthetics; D009466:Neuromuscular Blocking Agents; D007073:Immunoglobulin E